Purchase Order 36C25926P0120
Award Date 1/8/26
Potential Completion Date 1/11/26
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the purchase of specialty medications by the U.S. Department of Veterans Affairs (VA) from Accredo Health Group, Inc., a specialty pharmacy services provider. The contract award, valued at $2,603.79, is for the delivery of specific high-value medications to VA medical centers and facilities nationwide, supporting the Veterans Health Administration's (VHA) treatment programs. The contract is a firm fixed-price purchase order with no set-aside designation....
- Accredo Health Group, Inc. was awarded a $14,801.97 firm fixed price purchase order without a set-aside designation from the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 4. The contract is for the delivery of specialty pharmaceutical products to support VHA treatment programs for veterans located in Philadelphia, Pennsylvania. As the prime contractor, Accredo Health Group will distribute specialty medications directly to VA medical...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the express delivery of second quarter pharmacy orders with a ceiling value of $86,938.57 and a completion date of July 24, 2017. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...
- This federal contract award to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, was made by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for the delivery of specialty pharmaceutical products. The contract, valued at $138,543.43, is a firm fixed price purchase order without any set-aside designation. Accredo, as the prime contractor, provides specialty medications directly to VA medical centers and facilities across the country to...
- This federal contract award, with the ID VA25917E0551, was issued by the Department of Veterans Affairs (VA) to the prime contractor Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The award consists of 13 firm fixed-price purchase orders totaling $108,039.41, with an ultimate completion date of September 30, 2016. The contract does not have a set-aside designation. Accredo Health Group, Inc. has been a long-standing...
- This firm fixed-price purchase order, valued at $8,906.37, was awarded by the National Institutes of Health (NIH) Clinical Center to Accredo Health Group, Inc., a specialty pharmacy services provider. The contract is for the delivery of specific medications, such as Uptravi, Tyvaso, and Oxervate, to support treatment programs for the Veterans Health Administration (VHA). Accredo is a subsidiary of Express Scripts and has an established role as a key pharmaceutical distributor in the VA's...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical DUOPA. The $10,122.32 contract has a completion date of May 7, 2025 and was awarded on February 7, 2025 with no set-aside designation. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily...
- The U.S. Department of Veterans Affairs (VA) awarded a $43,162 firm fixed-price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical Prolastin. This contract is not associated with a set-aside program and has an ultimate completion date of June 30, 2024. Accredo Health Group, Inc., a subsidiary of Express Scripts, is a key distributor of complex and high-value medications, primarily serving the healthcare needs of...
- This is a federal contract award to Accredo Health Group, Inc., a prime contractor, by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 5. The contract is for the "RATIFICATION OF UNAUTHORIZED COMMITMENT" and "MEDICAL PRESCRIPTION" services, with a potential value of $130,050.45. The contract is a Firm Fixed Price Purchase Order with no set-aside designation, and the period of performance runs through March 31,...
- The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...